Sheri Barnes

Company: Labcorp Drug Development

Job title: Associate Director of Scientific Development

Seminars:

Assessing the Impact of PD1 Checkpoint Blockade in a Murine Model of Bladder Cancer by Immunophenotypic & Molecular Profiles 4:40 pm

Bladder cancer is the tenth leading cause of cancer-related deaths worldwide. Five checkpoint immunotherapies that target the PD-1/PD-L1 axis are FDA approved, and gene- and protein-based approaches are helping to identify new combination treatment strategies for therapeutic intervention. Using the murine MB49 model for bladder cancer, NanoString® and flow cytometry were used to provide gene…Read more

day: Day One